Physician profile
Marwan Abdulaal
NPI 1912316878
$3,405.22
in general payments reported to CMS, 2019-2025
17 companies · $1,159 in 2025
The $1,159 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $259 · 2021: $121 · 2022: $119 · 2023: $409 · 2024: $1,229 · 2025: $1,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,797.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $866.18 | 2023-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $587.02 | 2022-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $443.19 | 2023-2025 | Izervay |
| Alimera Sciences, INC. | $337.95 | 2019-2024 | Iluvien, Yutiq |
| Apellis Pharmaceuticals, INC. | $185.52 | 2024-2025 | Syfovre |
| Abbvie INC. | $183.48 | 2023-2025 | Ozurdex |
| Allergan, INC. | $175.51 | 2020 | |
| Ivantis, INC | $173.04 | 2020-2021 | |
| Regeneron Pharmaceuticals, INC. | $138.46 | 2025 | Eylea Hd |
| Astellas US LLC | $135.72 | 2024 | Izervay |
| Dutch Ophthalmic, USA | $66.61 | 2025 | Tissueblue, Eva, Combined Machine |
| Ani Pharmaceuticals, INC. | $27.27 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $21.70 | 2024 | Acthar |
| Glaukos Corporation | $18.59 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $17.64 | 2024 | Xdemvy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $14.32 | 2023 | Xiidra |
| Alcon Vision LLC | $13.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marwan Abdulaal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.